Tekla Healthcare Opportunities Fund (THQ) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 17 transactions totaling $798.9K, demonstrating a bullish sentiment with $798.9K in net insider flow. The most recent transaction on Jul 16, 2024 involved a purchase of 1,000 shares valued at $21.3K.
No significant insider buying has been recorded for THQ in the recent period.
No significant insider selling has been recorded for THQ in the recent period.
Based on recent SEC filings, insider sentiment for THQ is bullish with an Insider Alignment Score of 100/100 and a net flow of $798.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Tekla Healthcare Opportunities Fund (THQ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading THQ stock, having executed 17 transactions in the past 90 days. The most active insider is Daniel R. Omstead (Executive), who has made 6 transactions totaling $536.3K.
Get notified when executives and directors at THQ file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | Dimartino Rose | Executive | Purchase | 1,000 | $21.30 | $21.3K | |
| Apr 9, 2024 | Goetz Kathleen | Executive | Purchase | 600 | $19.54 | $11.7K | |
| Jan 2, 2024 | Reit Todd | Executive | Purchase | 1,000 | $18.44 | $18.4K | |
| Dec 28, 2023 | Maher Bill | Executive | Purchase | 1,000 | $18.25 | $18.3K | |
| Mar 23, 2022 | Goetz Kathleen | Executive | Purchase | 69.19 | $21.69 | $1.5K | |
| Jan 26, 2022 | Goetz Kathleen | Executive | Purchase | 479 | $21.73 | $10.4K | |
| Feb 25, 2021 | S. Reardon William | Executive | Purchase | 1,196 | $20.85 | $24.9K | |
| Sep 23, 2020 | Allen Bailey Jeffrey | Executive | Purchase | 570 | $17.68 | $10.1K | |
| Mar 17, 2020 | R. Omstead Daniel | Executive | Purchase | 7,300 | $14.67 | $107.1K | |
| Oct 25, 2018 | R. Omstead Daniel | Executive | Purchase | 6,000 | $17.43 | $104.6K | |
| Oct 17, 2018 | R. Omstead Daniel | Executive | Purchase | 5,902 | $18.19 | $107.4K | |
| Oct 11, 2018 | R. Omstead Daniel | Executive | Purchase | 5,500 | $17.59 | $96.7K | |
| Oct 10, 2018 | R. Omstead Daniel | Executive | Purchase | 5,500 | $18.27 | $100.5K | |
| Jan 25, 2018 | M. Kent Thomas | Executive | Purchase | 1,400 | $18.50 | $25.9K | |
| Dec 3, 2014 | H. Stebbins Lucinda | Executive | Purchase | 1,000 | $20.07 | $20.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $798.9K | 100.0% |
Insiders at Tekla Healthcare Opportunities Fund are accumulating shares at an accelerated pace. With 10 insiders making 17 transactions totaling $798.9K in purchases versus $0 in sales, the net buying activity of $798.9K signals strong executive confidence. Daniel R. Omstead (Executive) leads the buying activity with $536.3K in transactions across all time.